Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.75 |
| ▸ | CES1 | P23141 | 4/20 | 0.75 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.64 |
| ▸ | PPARG | P37231 | 7/20 | 0.64 |
| ▸ | PPARD | Q03181 | 7/20 | 0.64 |
| ▸ | PPARA | Q07869 | 7/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.64 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TLR2 | O60603 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233056 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL10961549 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL8741844 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL17315852 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL3016254 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL337998 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL337341 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL6817517 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL648617 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL174462 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679085-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | FIRMENICH SA (CH) | 2025-10-07 | — | — | US | claimed |
| CN-119097576-A | Preventing oxidation of flavor raw material and food raw material | 弗门尼舍有限公司 | 2024-12-10 | — | — | CN | claimed |
| WO-2024190666-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| CN-113038928-B | Preventing oxidation of flavor raw material and food raw material | 弗门尼舍有限公司 | 2024-08-30 | — | — | CN | claimed |
| US-20240166679-A1 | USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS | LYGG CORPORATION | 2024-05-23 | — | — | US | claimed |
| EP-4329743-A1 | PYRUVATE ESTERS FOR THE TREATMENT OF VIRAL DISEASES | Birkenmeier, Gerd (DE) | 2024-03-06 | — | — | EP | claimed |
| EP-4301831-A1 | USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS | LYGG Corporation (US) | 2024-01-10 | — | — | EP | claimed |
| CN-117222726-A | Use of ketoacids for stabilizing lignin in lignocellulosic biomass extraction processes | 理革公司 | 2023-12-12 | — | — | CN | claimed |
| CN-116759290-A | Passivation of germanium surfaces | 恩特格里斯公司 | 2023-09-15 | — | — | CN | claimed |
| EP-0130288-B1 | MICROBIOLOGICALLY PREPARED D-2-HYDROXY-4-METHYLPENTANOIC-ACID DEHYDROGENASE, PROCESS FOR ITS PRODUCTION AND ITS USE | Degussa Aktiengesellschaft (DE) | 1988-03-02 | — | — | EP | claimed |
| US-4699924-A | AMPHIPHILIC COMPONENTS, EMULSIFIER, ACTIVITY ENHANCER; 2-HYDROXYOCTANOIC ACID | LEVER BROTHERS COMPANY (US) | 1987-10-13 | — | — | US | claimed |
| EP-0232982-A2 | Treatment of skin disorders | UNILEVER PLC (GB) | 1987-08-19 | — | — | EP | claimed |
| US-4621150-A | METAL PERHALATE OR SULFONATE OR COMPLEX; GLYCIDATE, 2-HYDROXY-3-BUTENOATE, EPOXIDE | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1986-11-04 | — | — | US | claimed |
| US-4609623-A | LACTOBACILLUS OR LEUCONOSTOC | DEGUSSA AG (DE) | 1986-09-02 | — | — | US | claimed |
| EP-0153692-A2 | Method for isomerization a glycidate derivative | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1985-09-04 | — | — | EP | claimed |
| US-4507319-A | Skin treatment composition | LEVER BROTHERS COMPANY (US) | 1985-03-26 | — | — | US | claimed |
| EP-0117080-A2 | Skin treatment composition | UNILEVER PLC (GB) | 1984-08-29 | — | — | EP | claimed |
| EP-0086070-A2 | Skin treatment composition | UNILEVER N.V. (NL) | 1983-08-17 | — | — | EP | claimed |
| US-4152352-A | PRODUCTION OF ARYLPYRUVIC ACIDS | RHONE-POULENC INDUSTRIES (FR) | 1979-05-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166679-A1 | USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS | KHK, LCT, HOGA1 | CES2 366/4885CES1 257/4885HAO1 119/4885 |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | CUTA, MPO, GPX4 | CES2 540/4885CES1 504/4885HAO1 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.